University spinout PercayAI will analyze genomic and clinical data from WUSTL's McDonnell Genome Institute in search of potential coronavirus drug combinations.
The center, based in Barcelona, Spain, has built a search tool for quickly locating genetic variants and associated metadata for the novel coronavirus.
The grant will allow Weill Cornell to study genetic, social, and clinical factors that might explain why COVID-19 disproportionally affects minorities in the US.
Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
